FIRST LINE CHEMOTHERAPY OF FOLFOX REGIMEN IN AN INTERMITTENT REGIMEN IN A PATIENT WITH HER2-NEGATIVE GASTRIC CANCER

E.V. Dementeva1, O.I. Kaganov2, 3, I.B. Ermakov1 1Meditsinskaya Kompaniya IDK JSC, Samara 2Samara Regional Clinical Oncological Dispensary, Samara 3Samara State Medical University, Samara Dementeva E.V. – oncologist of the Department of Antitumor Therapy 29 Entuziastov St., 443067, Samara, Russian Federation, tel.: +7-917-152-21-27, e-mail: dementeva.ek98@mail.ru, ORCID ID: 0000-0001-9361-6354  Abstract. About one million new cases of gastric … Читать далее

POSSIBILITIES OF COMBINED IMMUNOTARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA. LITERATURE REVIEW

K.V. Menshikov1,2, A.V. Sultanbaev1, Sh.I. Musin1, I.R. Rakhmatullina2, I.A. Menshikova2, L.A. Khammatova3, E.V. Popova1, N.I. Sultanbaeva1, D.O. Lipatov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa 3Children’s City Polyclinic №9, Kazan Menshikov Konstantin V. ― Cand. of Sci. (Med.), Associate Professor of the Department of Oncology with courses on oncology and pathological anatomy … Читать далее